Evidence map›Paper›PMID 32212044›Full record

ArticleMetabolic brain disease2020

Histomorphological evaluations on the frontal cortex extrapyramidal cell layer following administration of N-Acetyl cysteine in aluminum induced neurodegeneration rat model.

Memudu Adejoke Elizabeth, Pantong Samson, Osahon Roli Itohan

Open access · hybridAbstract read
In one paragraph

Article in Metabolic brain disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Hepatoprotective potential ofToxicology reports · 2023
    Article
  9. Article
  10. Anatomy & cell biology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Memudu Adejoke ElizabethDepartment of Anatomy, Faculty of Basic Medical Sciences, College of Medical Sciences, Edo University Iyamho, KM 7 Auchi-Abuja Expressway, Iyamho, Edo State, Nigeria. jokememudu@gmail.com.
Pantong SamsonJiangxi University of Traditional Chinese Medicine, 818 Xingwanli Avenue, Wanli District, Nanvhang City, Jiangxi Province, China.
Osahon Roli ItohanDepartment of Anatomy, Faculty of Basic Medical Sciences, College of Medical Sciences, Edo University Iyamho, KM 7 Auchi-Abuja Expressway, Iyamho, Edo State, Nigeria.
Edo State University Uzairue · NGBingham University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aluminum is a potent neurotoxin used in animal models of neurodegenerative diseases like Alzheimer's disease (AD), in which oxidative stress mediates tissue pathogenesis in vivo. N-acetyl cysteine (NAC) is a glutathione precursor with reported antioxidant and neuroprotective potentials. Recent therapy for combating AD is known to provide only symptomatic relief thus necessitating the discovery of new drugs and their mechanism of action. This study was aimed to demonstrate the in vivo neuroprotective effect of NAC against aluminum (Al

Indexed as

AluminumAcetylcysteineAluminum ChlorideAlzheimer DiseaseAnimalsAntioxidantsAstrocytesExtrapyramidal TractsGlial Fibrillary Acidic ProteinGliosisMaleNecrosisNeurodegenerative DiseasesNeuronsNeuroprotective AgentsOxidative StressAcetylcysteineAluminumAluminum ChlorideAntioxidantsGlial Fibrillary Acidic ProteinNeuroprotective AgentsAluminumAstrocytes and oxidative stressChromatolysisN-acetyl cysteine (NAC)

Identifiers

PMID32212044
PMCPMC7220982
OpenAlexW3013686185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.